These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8678696)

  • 21. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case report. A patient with idiopathic ventricular tachycardia.
    Venkata KI; Rahmat B; Kacharava G; Avaliani I
    Georgian Med News; 2008 Nov; (164):43-5. PubMed ID: 19075341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of flecainide for refractory atrial tachycardia of pregnancy.
    Ahmed K; Issawi I; Peddireddy R
    Am J Crit Care; 1996 Jul; 5(4):306-8. PubMed ID: 8811156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracoronary flecainide induces ST alternans and reentrant arrhythmia on intact canine heart: A role of 4-aminopyridine-sensitive current.
    Tachibana H; Yamaki M; Kubota I; Watanabe T; Yamauchi S; Tomoike H
    Circulation; 1999 Mar; 99(12):1637-43. PubMed ID: 10096943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplacental flecainide therapy in the treatment of fetal supraventricular tachycardia.
    D'Souza D; MacKenzie WE; Martin WL
    J Obstet Gynaecol; 2002 May; 22(3):320-2. PubMed ID: 12521516
    [No Abstract]   [Full Text] [Related]  

  • 26. Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.
    Padfield GJ; AlAhmari L; Lieve KV; AlAhmari T; Roston TM; Wilde AA; Krahn AD; Sanatani S
    Heart Rhythm; 2016 Feb; 13(2):609-13. PubMed ID: 26416620
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of magnesium on polymorphic ventricular tachycardias induced by aconitine.
    Adaniya H; Hayami H; Hiraoka M; Sawanobori T
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):721-9. PubMed ID: 7532749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the in vivo hemodynamic effects of the antiarrhythmic agents vernakalant and flecainide in a rat hindlimb perfusion model.
    Allison B; Yang Y; Pourrier M; Gibson JK
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):463-8. PubMed ID: 21283020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction.
    Hashimoto H; Katoh H; Nakashima M
    J Pharmacobiodyn; 1992 May; 15(5):191-201. PubMed ID: 1527695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GAP-134 ([2S,4R]-1-[2-aminoacetyl]4-benzamidopyrrolidine-2-carboxylic acid) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.
    Hennan JK; Swillo RE; Morgan GA; Rossman EI; Kantrowitz J; Butera J; Petersen JS; Gardell SJ; Vlasuk GP
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):207-14. PubMed ID: 19721133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute treatment of stable hemodynamically tolerable ventricular tachycardia].
    Haverkamp W; Rolf S; Stockburger M; Dietz R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):207-12. PubMed ID: 15832239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic effects of growth hormone--in vivo evidence from small-animal models of acute myocardial infarction and invasive electrophysiology.
    Råmunddal T; Gizurarson S; Lorentzon M; Omerovic E
    J Electrocardiol; 2008; 41(2):144-51. PubMed ID: 18328337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatiotemporal dynamics of reentrant ventricular tachycardias in canine myocardial infarction: pharmacological modulation.
    Hélie F; Vinet A; Cardinal R
    Can J Physiol Pharmacol; 2003 May; 81(5):413-22. PubMed ID: 12774847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intravenous magnesium in a prolonged QT interval model of polymorphic ventricular tachycardia focus on transmural ventricular repolarization.
    Chinushi M; Sugiura H; Komura S; Hirono T; Izumi D; Tagawa M; Furushima H; Aizawa Y
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):844-50. PubMed ID: 16105013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Flecainide acetate].
    Bordier P; Garrigue S; Clémenty J
    Ann Cardiol Angeiol (Paris); 1996 May; 45(5):263-79. PubMed ID: 8763646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effective dose of flecainide for arrhythmia in children].
    Sumitomo N; Ushinohama H; Hara M; Otuka M; Harada K; Okuni M
    Kokyu To Junkan; 1993 Nov; 41(11):1079-82. PubMed ID: 8256048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia.
    Biernacka EK; Hoffman P
    Europace; 2011 Jan; 13(1):129-30. PubMed ID: 20798117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.